|1.||Huang, Peng: 2 articles (11/2014 - 02/2014)|
|2.||Sun, Tao: 2 articles (11/2014 - 02/2014)|
|3.||Ge, Chunlin: 2 articles (11/2014 - 02/2014)|
|4.||Rust, Christian: 2 articles (09/2013 - 07/2005)|
|5.||Liu, Mingqiang: 2 articles (04/2013 - 12/2011)|
|6.||Li, Peifeng: 2 articles (04/2013 - 12/2011)|
|7.||Guan, Hong: 2 articles (04/2013 - 12/2011)|
|8.||Li, Lei: 2 articles (04/2013 - 12/2011)|
|9.||Piazza, F: 2 articles (05/2000 - 01/2000)|
|10.||Roda, A: 2 articles (05/2000 - 01/2000)|
07/28/2008 - "Infusion of Taurochenodeoxycholate (TCDCA) represents a model of bile salt-induced cholestasis in rat. "
12/05/2010 - "In the present study, we analyzed the capacity of the ursodeoxycholic acid endogenous metabolite, tauroursodeoxycholate (TUDC), to stabilize the hepatocellular plasma membrane against its transition to the micellar phase induced by the tensioactive bile salt taurochenodeoxycholate (TCDC), the main endogenous bile salt accumulated in cholestasis. "
07/01/2005 - "Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers."
03/01/1996 - "Estradiol-17beta-D-glucuronide interacts with MDR1, and taurochenodeoxycholic acid and lithocholate-3-O-glucuronide may interact with vesicular transport system, each of which may relate with the genesis of cholestasis. "
10/01/1994 - "Infusion of taurochenodeoxycholate (0.22 mumol/min/gm liver) did not produce cholestasis and did not reduce the biliary excretion of bile acids in the Eisai hyperbilirubinemic rats. "
10/01/1982 - "In gallstone-susceptible squirrel monkeys, corn oil tended to decrease the bile acid pool size and decrease the percentage of taurochenodeoxycholic acid. "
01/01/2008 - "In order to interpret the clinical efficacy of conjugated ursodeoxycholate (UDC) in cholesterol (Ch) gallstone patients, the Ch solubilization in mixed micelles in 40:40:32 mM tauroursodeoxycholate (TUDC):taurochenodeoxycholate (TCDC):lecithin (L) and 80:32 mM TUDC:L systems was estimated by using a model of Ch binding to mixed micelles. "
12/01/1995 - "Seventy radiolucent gallstones with similar size and composition (cholesterol content, 70.1 +/- 0.9%) from a single patient were incubated in model biles composed of 100 mM of either taurochenodeoxycholate (TCDC), taurocholate (TC), taurohyodeoxycholate (THDC) or tauroursodeoxycholate (TUDC) and of 45 mM egg yolk lecithin in saline buffered with tris/HCl (at pHs 7 and 8) or phosphate (at pHs 4 and 6). "
12/01/1993 - "The gallstone diet decreased the concentration of bile acids in gallbladder bile, but greatly increased the percentage of taurochenodeoxycholic acid, whereas psyllium preferentially decreased all taurine-conjugated bile acid levels and expanded glycocholate output. "
05/01/1997 - "Taurochenodeoxycholic acid ameliorates and ursodeoxycholic acid exacerbates small intestinal inflammation."
05/01/1997 - "Taurochenodeoxycholic acid (TCDCA) significantly normalized the clinical inflammatory parameters, prevented indomethacin-induced increases in the biliary contents of secondary bile acids and hydrophobicity index, and tended to attenuate the intestinal inflammation. "
|4.||Pulmonary Fibrosis (Hamman Rich Syndrome)
07/01/2013 - "The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice."
07/01/2013 - "The present study prepared the pulmonary fibrosis model in mice by using Bleomycin and carry out the investigations on the effects of taurochenodeoxycholic acid (TCDCA) in preventing pulmonary fibrosis in mice. "
|1.||Ursodeoxycholic Acid (Urso)
|2.||Taurocholic Acid (Sodium Taurocholate)
|9.||Bile Acids and Salts (Bile Acids)